We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue to Study Completion

Product News   Feb 24, 2011

 
Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue to Study Completion
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Sygnature Discovery Announces Collaboration With Software Firm SilcsBio

Product News

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has today announced a collaboration with SilcsBio, a scientific software company focused on high-throughput fully atomistic simulations of protein targets and protein-ligand structures.

READ MORE

Jackson ImmunoResearch Launches Secondary Antibodies for VHH Discovery

Product News

Anti-Alpaca IgG, Subclass and VHH domain secondary antibodies to optimize VHH (single-domain) antibody development and application.

READ MORE

Thermo Fisher Scientific Announces Collaboration to Advance Biopharmaceutical Characterization and Monitoring Methods

Product News

Thermo Fisher and Genovis to develop advanced end-to-end workflows for biotherapeutics analysis.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE